Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement.

about

Analysis of prognostic factors in patients with newly diagnosed diffuse large B-cell lymphoma and skeletal involvement.

Item

http://www.wikidata.org/entity/Q36279071

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Analysis of prognostic factors ...... homa and skeletal involvement.

@ast

Analysis of prognostic factors ...... homa and skeletal involvement.

@en

type

Item

label

Analysis of prognostic factors ...... homa and skeletal involvement.

@ast

Analysis of prognostic factors ...... homa and skeletal involvement.

@en

prefLabel

Analysis of prognostic factors ...... homa and skeletal involvement.

@ast

Analysis of prognostic factors ...... homa and skeletal involvement.

@en

P1476

Analysis of prognostic factors ...... homa and skeletal involvement.

@en

P2093

Axel Benner

http://www.w3.org/2001/XMLSchema#string

Isabelle Krämer

http://www.w3.org/2001/XMLSchema#string

Maral Saadati

http://www.w3.org/2001/XMLSchema#string

Mathias Witzens-Harig

http://www.w3.org/2001/XMLSchema#string

Nicola Lehners

http://www.w3.org/2001/XMLSchema#string

P2860

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Modified number of extranodal involved sites as a prognosticator in R-CHOP-treated patients with disseminated diffuse large B-cell lymphoma

Localised lymphoma of bone: prognostic factors and treatment recommendations. The Princess Margaret Hospital Lymphoma Group

State-of-the-art therapeutics: diffuse large B-cell lymphoma.

Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).

Primary and secondary bone lymphomas.

Mechanisms of bone lesions in multiple myeloma and lymphoma.

Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.

P2888

s12885-017-3113-z

P304

128

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3113-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anthony D Ho

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083812288

http://www.w3.org/2001/XMLSchema#string

P698

28193188

http://www.w3.org/2001/XMLSchema#string

P932

5307829

http://www.w3.org/2001/XMLSchema#string